Anticipating HCP Prescribing Behavior Pre-Diagnosis: PulsePoint’s Approach to Rare Disease Omnichannel Marketing Efficiency
In rare disease marketing, timing is one of the most crucial components of a prescriber choosing your treatment. Traditional claims-based targeting often activates 30 days after diagnosis, when treatment decisions are already in motion. PulsePoint helped a pharmaceutical brand move messaging earlier in the clinical journey by identifying high-probability prescribers before patient diagnosis, when treatment considerations were actively forming.
Using a predictive, multi-signal targeting framework, PulsePoint combined real-time digital engagement, clinical procedure patterns, and brand interactions to continuously identify and engage HCPs during narrow, high-impact windows. The approach was powered by PulsePoint’s connected omnichannel ecosystem and core product offerings: HCP Explorer, HCP365, and Life.
The results speak for themselves:
The results validate that greater impact comes from reaching fewer physicians at the right moment, not broader, untimed coverage.
See how you can replicate the results.
Get the case study →
